[1]郭金莲,徐炜棉,卢均坤.PiC基因与人体疾病机制研究[J].医学信息,2018,31(22):23-25.[doi:10.3969/j.issn.1006-1959.2018.22.008]
 GUO Jin-lian,XU Wei-mian,LU Jun-kun.Research Progress of PiC Gene and Human Disease Mechanism[J].Journal of Medical Information,2018,31(22):23-25.[doi:10.3969/j.issn.1006-1959.2018.22.008]
点击复制

PiC基因与人体疾病机制研究()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年22期
页码:
23-25
栏目:
综述
出版日期:
2018-11-15

文章信息/Info

Title:
Research Progress of PiC Gene and Human Disease Mechanism
文章编号:
1006-1959(2018)22-0023-03
作者:
郭金莲1徐炜棉1卢均坤2
(1.佳木斯大学,黑龙江 佳木斯 154000;2.佳木斯大学附属第一医院心内二科,黑龙江 佳木斯 154000)
Author(s):
GUO Jin-lian1XU Wei-mian1LU Jun-kun2
(1.Jiamusi University,Jiamusi 154000, Heilongjiang,China;2.Department of Cardiology,Subject Two,the First Affiliated Hospital of Jiamusi University, Jiamusi 154000,Heilongjiang,China)
关键词:
PiCMPTP线粒体
Keywords:
PiCMPTPMitochondria
分类号:
R542.2
DOI:
10.3969/j.issn.1006-1959.2018.22.008
文献标志码:
A
摘要:
线粒体功能的改变,直接导致人体多种病变,影响线粒体功能的原因有很多种,其中线粒体磷酸转载体(PiC)作为线粒体内膜的膜蛋白,对线粒体通透性转换孔(MPTP)的开放起到至关重要的作用,因此通过不断的研究与发现,PiC基因的表达与多种疾病的发生发展有关,现就PiC基因与人体疾病机制的研究进展情况予以综述。
Abstract:
Mitochondria function changes directly lead to a variety of diseases in the human body. There are many factors that affect Mitochondria function. Among them, the Mitochondria Phosphoric acid carrier vector (PiC) is the membrane protein of the Mitochondria intima. It plays a vital role in the opening of the Mitochondria permeability transition pore (MPTP). So through constant research and discovery, PiC gene expression is related to the occurrence and development of various diseases. This paper summarizes the research progress of PiC gene and human disease mechanism.

参考文献/References:


[1]Fonyo A,Bessman SP.Inhibition of inorganic phosphate penetration into liver mitochondria by p -mercuribenzoate[J].Biochemical Medicine,1968,2(2):145-163.
[2]Leung AWC,Varanyuwatana P,Halestrap AP.The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition[J].The Journal of Biological Chemistry,2008,283(39):26312-26323.
[3]Varanyuwatana P,Halestrap AP.The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore[J].Mitochondrion,2012,12(1):120-125.
[4]Jafri MS,Kumar R.Modeling mitochondrial function and its role in disease[J].Prog Mol Biol Transl Sci,2014(123):103-125.
[5]Halestrap AP.What is the mitochondrial permeability transition pore[J].J Mol Cell Cardiol,2009,46(6):821-831.
[6]Leung AW,Halestrap AP.Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore[J].BiochimBiophys Acta,2008(1777):946-952.
[7]Wei AC,Liu T,O'Rourke B.Dual Effect of Phosphate Transport on Mitochondrial Ca2+ Dynamics[J].J Biol Chem,2015,290(26):16088-16098.
[8]Baeza J,Smallegan MJ,Denu JM.Mechanisms and dynamicsof protein acetylation in mitochondria[J].Trends Biochem,2016(41):231-244.
[9]Parodirullán RM,Chapadubocq X,Rullán PJ,et al.High Sensitivity of SIRT3 DeficientHearts to Ischemia-Reperfusion IsAssociated with MitochondrialAbnormalities[J].Frontiers in Pharmacology,2017(8):439.
[10]Camara AK,Bienengraeber M,Stowe DF.Mitochondrialapproaches to protect against cardiac ischemia andreperfusion injury[J].Front Physiol,2011(2):13.
[11]Leung AW,Varanyuwatana P,Halestrap AP.The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition[J].The Journal of biologicalchemistry,2008(283):26312-26323.
[12]乔智力,王媛媛,丁兆敏,等.大鼠缺血性心肌损伤中线粒体磷酸转载体的表达情况及姜黄素的保护作用研究[J].临床和实验医学杂志,2016,15(23):2290-2293.
[13]Sloan RC,Moukdar F,Frasier CR,et al.Mitochondrial permeability transition in the diabeticheart: contributions of thiol redox state and mitochondrial calciumto augmented reperfusion injury[J].J Mol Cell Cardiol,2012(52):1009-1018.
[14]Cesura AM,Pinard E,Schubenel R,et al.Thevoltage-dependent anion channel is the target for a new class of inhibitors of themitochondrial permeability transition pore[J].J Biol Chem 2003,278(50):49812-49818.
[15]Skladal D,Halliday J.Thorburn DR Minimum birthprevalence of mitochondrial respiratory chain disorders inchildren[J].Brain,2003(126):1905-1912.
[16]Mayr JA,Merkel O,Kohlwein SD,et al.Mitochondrial Phosphate-Carrier Deficiency:A Novel Disorder of Oxidative Phosphorylation[J].Am J Hum Genet,2007,80(3):478-484.
[17]Baseler WA,Thapa D,Jagannathan R,et al.miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart[J].AmJPhysiol Cell Physiol,2012,303(12):C1244-C1251.
[18]Tsujimoto Y,Cossman J,Jaffe E,et al.Involvementof the bcl-2 gene in human follicular lymphoma[J].Science,1985,228(4706):1440-1443.
[19]Chen Z,Chua CC,Ho YS,et al.Overexpressionof Bcl-2 attenuates apoptosis and protectsagainst myocardial I/R injury in transgenic mice[J].AmJPhysiol Heart Circ Physiol,2001(280):H2313-H2320.
[20]Li K,Li Y,Shelton JM,et al.Cytochrome c deficiency causes embryonic lethality and attenuates stress induced apoptosis[J].Cell,2000,10(1):389-399.
[21]Chen Q,Xu H,Xu A,et al.Inhibition of Bcl-2 sensitizesmitochondrial permeability transition pore (MPTP) openingin ischemia-damaged mitochondria[J].PLoS ONE,2015,10(3):e0118834.
[22]Galluzzi L,Blomgren K,Kroemer G.Mitochondrial membrane permeabilization in neuronal injury[J].Nat Rev Neurosci,2009(10):481-494.
[23]Haworth RA,Hunter DR.The Ca2+-induced membrane transition in mitochondria.Ⅱ.Nature of the Ca2+ trigger site[J].Arch Biochem Biophys,1979,195(2):460-467.
[24]Jonas EA,Porter GA,Alavian KN.Bcl-xl in neuroprotection and plasticity[J].Frontiers in physiology,2014(5):355.
[25]Baines CP,Molkentin JD.Adenine nucleotide translocase-1 induces cardiomyocyte death through upregulation of the pro-apoptotic protein Bax[J].J Mol Cell Cardiol,2009,46(6):969-977.
[26]Perciavalle RM,Stewart DP,Koss B,et al.Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration[J].Nature cell biology,2012(14):575-583.

更新日期/Last Update: 2018-12-03